Posted inResearch
Akari locks arms with WuXi XDC to develop and manufacture novel ADC treatment
Oncology biotech Akari Therapeutics has announced a partnership with WuXi XDC, an antibody-drug conjugate (ADC) development and manufacturing company, to…









